Trials / Completed
CompletedNCT03770468
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 599 (actual)
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This pro - and retrospective multicenter clinical epidemiological study studies the molecular genetic, host-derived and clinical determinants of glioblastoma patients with an overall survival of more than 5 years. The different research focusses are: * Identification of clinical parameters and patient characteristics / host-related factors in long-term survivors (Focus 1) * Identification of molecular tumor characteristics in long-term survivors (Focus 2) * Assessment of therapy-related parameters, including neuro-toxicity (Focus 3) * Immunological studies (Focus 4)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood drawl |
Timeline
- Start date
- 2015-07-05
- Primary completion
- 2023-08-18
- Completion
- 2023-08-18
- First posted
- 2018-12-10
- Last updated
- 2024-03-08
Locations
27 sites across 9 countries: United States, Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Switzerland
Source: ClinicalTrials.gov record NCT03770468. Inclusion in this directory is not an endorsement.